China Resources Sanjiu Reports Rising Profits Despite Cash Decline
Company Announcements

China Resources Sanjiu Reports Rising Profits Despite Cash Decline

China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.

China Resources Sanjiu Medical & Pharmaceutical Co., a subsidiary of China Resources Pharmaceutical Group Ltd., reported a significant rise in net profit to RMB 3.24 billion for the nine months ending September 30, 2024, up from RMB 2.69 billion the previous year. Despite this profit boost, the company experienced a decrease in cash and cash equivalents, ending the period with RMB 5.39 billion. Investors are advised to exercise caution as these unaudited financial results may be subject to adjustments.

For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskChina Resources Pharmaceutical Completes Green Cross HK Acquisition
TipRanks HongKong Auto-Generated NewsdeskChina Resources Subsidiary Reports Revenue Surge Amid Cash Challenges
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App